HEPATOPROTECTIVE EFFECT OF BELLAMYA JAVANICA: ASPARTATE TRANSAMINASE, ALANINE AMINOTRANSFERASE, AND ALKALINE PHOSPHATASE ACTIVITY, AND LIVER HISTOPATHOLOGY IN MICE INDUCED WITH CARBON TETRACHLORIDE by Saputri, Fadlina Chany et al.
ISSN - 0975-7058 
Vol 10, Special Issue 1, 2018
HEPATOPROTECTIVE EFFECT OF BELLAMYA JAVANICA: ASPARTATE TRANSAMINASE, 
ALANINE AMINOTRANSFERASE, AND ALKALINE PHOSPHATASE ACTIVITY, AND LIVER 
HISTOPATHOLOGY IN MICE INDUCED WITH CARBON TETRACHLORIDE
FADLINA CHANY SAPUTRI1*, CAROLINA ASTARI1, DYAH ADINDA JANATRY1, AZIZAHWATI1, DADANG KUSMANA2
1Departmentof Pharmacology, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia.  2Department ofBiology, Faculty of 
Mathematics and Natural Sciences, Universitas Indonesia, Depok 16424, Indonesia.  Email: fadlina.chany@farmasi.ui.ac.id
Received: 10 April 2018, Revised: 28 September 2018, Accepted: 25 November 2018
ABSTRACT
Objective: The aim of this study was to evaluate the hepatoprotective effects of Bellamya javanica meat (BJM) in mice by quantifying alanine 
aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) activity and observing liver histology.
Methods: A total of 36 white male Sprague-Dawley mice were divided into six groups, namely a normal control group, a negative control group (0.5% 
carboxymethyl cellulose), a positive control group (silymarin with a dosage of 9.45 mg/200 g mouse weight), dosage 1 group (BJM powder at 1 g/kg 
mouse weight), dosage 2 group (BJM powder at 2 g/kg mouse weight), and dosage 3 group (BJM powder at 4 g/kg mouse weight). Mice were treated 
for 14 days. On the 15th day, all groups (except the normal control group) were induced with carbon tetrachloride and fed ad libitum. After 24 h of 
induction, ALT, AST, and ALP in serum were quantified, and livers were dissected for histopathological examination.
Results: The results showed that the consumption of BJM at doses of 2 and 4 g/kg mouse weight cast a hepatoprotective effect compared with the 
negative control group. In addition, there were significant differences in the hepatoprotective effect between the various doses of BJM. The dosage 
with the highest potential hepatoprotective effect was 4 g/kg mouse weight (p<0.05).
Conclusion: B. javanica has potential hepatoprotective effects, with the strongest protection occurring at a 4 g/kg mouse weight dosage. 
Hepatoprotection was observed in the form of decreased AST, ALT, and ALP activity and relevant changes in liver histopathology.
Keywords: Alanine aminotransferase, Alkaline phosphatase, Aspartate transaminase, Bellamya javanica, Liver histology.
INTRODUCTION
The liver is highly susceptible to damage next to the digestive system 
due to its exposure to toxins. Liver damage is primarily caused by 
exogenous compounds, such as certain drugs and pollutants, present 
in toxic chemicals. Examples of compounds that can elicit liver damage 
include paracetamol (acetaminophen), carbon tetrachloride (CCl4), 
thioacetamide, and alcohol (ethanol) [1-3].
Liver damage typically results in cellular necrosis, increased lipid 
peroxidation, and decreased glutathione (GSH) levels. In addition, the 
serum activity of various biochemical markers, including aspartate 
transaminase (AST), alanine aminotransferase (ALT), triglycerides, and 
alkaline phosphatase (ALP), also increases [4].
Bellamya javanica, a gastropod abundant in Indonesia, is a natural 
ingredient, believed by civilians, to be effective in maintaining liver 
health [5,6]. It is consumed as part of regular meal to help prevent liver 
disease. The consumption of B. javanica meat (BJM) is believed by the 
traditional community to strengthen bones and to treat ailments, such 
as gastritis, arthritis, and various liver disorders [7].
Although the specific contents of B. javanica have not been identified, 
the related gastropod Bellamya bengalensis has been shown to possess 
a high protein content [8]. In addition, B. bengalensis has been shown to 
cast hepatoprotective effects as it has the ability to significantly decrease 
the activity of important liver biochemical markers (AST, ALT, and ALP) 
in male Wistar mice induced with CCl4 [7]. Therefore, the related B. 
javanica may also cast hepatoprotective effects thanks to its proteins that 
play an important role in the biosynthesis of GSH, a critical antioxidant 
that protects against the free radicals that may cause liver damage [9].
MATERIALS AND METHODS
Materials
B. javanica was gathered from paddy fields in Cianjur and was further 
analyzed at the Indonesian Scientific Research and Development Center 
or the Pusat Penelitian dan Pengembangan Lembaga Ilmu Pengetahuan 
Indonesia located in Bogor (No. 050a/IIPI.1.02/K5.02/II/2015). The 
conventional hepatoprotective agent used as a positive control in 
this study was silymarin (Nature’s Bounty, New York). Hepatotoxic 
induction was conducted with CCl4 (Merck, USA and Canada) diluted in 
coconut oil (Barco, Indonesia) at a 1:1 ratio.
Test material preparation
Fresh B. javanica was washed with running water and boiled at low 
heat, and the meat was extracted from its shell. The operculum was 
then separated from the meat and weighed. The BJM was pureed with 
aquadest using a blender and then placed in a freeze-dryer bottle and 
frozen for 24 h. After the samples were frozen, the bottles containing the 
frozen BJM were placed in a freeze-dryer machine (Scanvac Coolsafe, 
Denmark) for several days until the meat become consistent with 
powder, which was then smoothed again [10]. The B. javanica dried 
meat powder was then suspended in 0.5% carboxymethyl cellulose 
(CMC) at dosages of 1, 2, and 4 g/kg mouse weight to be administered 
orally.
Qualitative test
Qualitative tests on the BJM powder were performed to identify its 
protein content. The Biuret test, Xanthoproteic test, Millon’s test, 
and lead acetate test were conducted. The results from these tests 
confirmed that the BJM contained protein.
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Animal testing
The animals used in this study included 42 white male Sprague-Dawley 
mice (BPOM) aged 8 weeks and weighing 150–200 g. Before being 
treated, mice were acclimatized for 14 days in the Animal Testing 
Laboratory, Faculty of Pharmacy, Universitas Indonesia (No. 255/UN2.
F1/ETIK/2015). The general condition and weight of the mice were 
observed during the acclimatization period to select healthy mice 
for the study. This study passed the ethical review from the Health 
Research Ethics Committee, Faculty of Medicine, Universitas Indonesia.
Preliminary test
Preliminary testing was conducted to determine the dosage and the amount 
of days BJM powder were to be given. Preliminary testing was performed 
by dividing seven mice into three groups. The first group consisted of one 
mouse as a control group, while the second and third groups consisted of 
two mice each, one as a control and one to be given treatment (Table 1).
After the last BJM suspension was given, mice were left alone for 24 h 
and then induced with CCL4 diluted in coconut oil (1:1) at a dosage of 
1 mL/kg mouse weight [11-13]. After the mice were induced, they were 
fed ad libitum for 24 h. After 48 h, mice were anesthetized with ether, 
and blood from the orbital sinus was extracted and measured for its 
plasma ALT and AST levels.
Hepatoprotective activity test
Pre-treatment animal testing
Pre-treatment experiments were performed in which the test animals 
were given silymarin and BJM according to each group dosage for 
14 days. The animals were randomly divided into six groups as 
described in Table 2.
Hepatotoxic induction
After 14 days of pretreatment, test animals were induced for 24 h after 
the last treatment was given to all treatment groups, excluding the 
normal control group. After they were induced with CCl4, the mice were 
fed ad libitum for 24 h. The test animals were then anesthetized with 
ether, and blood samples were taken from the orbital sinus. Livers were 
also extracted for histopathological analysis.
Blood withdrawal
Blood was withdrawn from the orbital sinus and collected in K2 
ethylenediaminetetraacetic acid Vacutainer to prevent coagulation. 
Samples were then centrifuged at a speed of 3000 rpm for 5 min to 
extract the plasma, and a plain vacutainer was left to be separated at 
room temperature followed by centrifugation at 3000 rpm for 15 min 
to extract the serum.
AST, ALT, and ALP quantification
The selection of kinetic methods used to quantify AST and ALT activity 
was based on recommendations from the IFCC (International Federation 
of Clinical Chemistry) Expert Panel, without pyridoxal phosphate 
activation. AST and ALT activity quantification was performed at a 
wavelength of 340 nm and a temperature of 25°C. Serum ALP activity 
was quantified using a colorimetry kit (Human, Germany).
Histopathology
Isolated livers were placed inside a beaker containing 0.9 M NaCl. 
The fixation solution used in this study was the Bouin solution, which 
consists of 5% saturated picric acid (75 mL), 40% formalin (25 mL), 
and glacial acetic acid (5 mL). Histological staining of the liver was 
performed using hematoxylin and eosin. Observation of the liver 
preparation was done semiquantitatively and quantitatively using a 
light microscope (Novex, Holland). The observed parameters included 
the diameter of the central vein and damage to the liver parenchymas, 
such as liver necrosis, steatosis, fibrosis, and liver cirrhosis. 
Semiquantitative observation was performed on 50 liver lobes from 
one preparation for each treatment group by determining the degree 
of central vein and parenchymal damage (Table 3). The quantitative 
observation was performed by measuring the central vein diameter 
using a micro projector (Ken-A-Vision, USA).
Data analysis
The obtained data included plasma AST and ALT activity, serum ALP 
activity, and central vein diameters and were statistically analyzed using 
SPSS 21.0. We used parametric tests such as the normal distribution 
test (Shapiro–Wilk test) and the homogeneity test (Levene’s test), as 




The results of the preliminary tests are shown in Table 4. These results 
show that in the dosage 2 treatment group, a decrease in plasma ALT 
and AST levels were observed; these levels approached normal levels 
after 14 days. A weight of 2 g/kg was determined as the median dose of 
the hepatoprotective activity test.
Hepatoprotective activity test
The mean activity of AST, ALT, and ALP from each group can be seen 
in Table 5. All three enzymes show a decrease as the dosage of BJM 
increases, thus demonstrating a dose-response relationship.
The results of our analysis show that the mean diameter of the central 
vein was significantly different between the negative control group 
Table 1: Treatment given to the mice in the preliminary test
Groups Duration of treatment
1 week 2 weeks 3 weeks
Normal control Given CMC 0.5% 3 mL/200 g mouse weight
Negative control Given CMC 0.5% 3 mL/200 g mouse weight
Treatment Given BJM suspension 2 g/kg bb mouse
BJM: Bellamya javanica meat. CMC: Carboxymethyl cellulose
Table 2: Division of animal testing groups
No. Group Treatment 24 h after last treatment 48 h after last 
treatment 
I Normal control 3 mL/200 g weight 0.5% CMC solution given orally 1 mL/kg weight coconut oil 
orally
Blood withdrawal, 
plasma ALP activity 
quantification, liver 
extraction, and heart 
histology preparation 
II Negative control 3 mL/200 g weight 0.5% CMC solution given orally Induced with 0.5 mL/kg weight 
CCl4 in coconut oil (1:1) orallyIII Positive control Silymarin suspended in 0.5% CMC 9.45 mg/200 g weight 
dose given orally
IV Dosage 1 BJM suspended in 0.5% CMC with 1 g/kg weight dose given 
orally
V Dosage 2 BJM suspended in 0.5% CMC with 2 g/kg weight dose given 
orally
VI Dosage 3 BJM suspended in 0.5% CMC with 4 g/kg weight dose given 
orally
ALP: Alkaline phosphatase, BJM: Bellamya javanica meat. CMC: Carboxymethyl cellulose, CCl4: Carbon tetrachloride
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and the treatment control groups of 1 g/kg weight and 4 g/kg weight 
snail meat. The dosage that produced the strongest hepatoprotective 
effect was 4 g/kg weight (p<0.05). The dose of 1 g/kg weight snail meat 
powder demonstrated a lower hepatoprotective effect compared with 
the negative control group (p>0.05). Similar to the ALP activity, the 
mean diameter of the central vein in the treatment group with 4 g/kg 
weight differed from that of the normal control group (p>0.05).
On the basis of the mean liver damage percentage of the normal control 
group, it was observed that 100% of the livers experienced only a 
Level 1 damage (minor damage). The mean liver damage percentage 
of the induced control group showed a decrease in the Level 1 damage 
percentage and an increase in the Level 2 damage, but no increase in 
Level 3 damage (Fig. 1).
A decrease in damaged hepatocyte size and the number and 
amount of neutrophil infiltration in the central vein were seen 
histologically with BJM treatment. Sinusoids fill the empty spaces 
between hepatocytes and spread peripherally to the central vein. 
The histological view of the normal control group can be seen in 
Fig. 2a. The largest damage was seen in the negative control group, 
which was administered a toxic dose of CCl4 (1 mL/kg weight; Figs. 
2b and 3). It shows neutrophil infiltration as a result of damage to 
the hepatocyte cell membrane. Microanatomical healing can be seen 
in the treatment group of 1 g/kg weight dosage as described in Fig. 2c. 
However, this healing is much more noticeable in groups treated with 
BJM at 2 g/kg weight and 4 g/kg weight, as shown in Fig. 2d and e. 
The dosage 1 group still shows heavy neutrophil infiltration, which 
is a marker of inflammation, caused by hepatocyte damage and free 
radicals from CCl4 metabolism [14].
Treatment groups that were given BJM at various doses showed a 
decrease in the damage percentage as the dose of BJM increased. The 
steepest decrease in liver damage was seen in the treatment group 
administered a BJM dose of 4 g/kg weight that presented with Level 1 
damage (66.67%) and Level 2 damage (33.33%). Histological analysis 
showed a decrease in hepatocyte size and number, as well as neutrophil 
infiltration in the central vein.
DISCUSSION
Qualitative tests were conducted to verify the protein content in the 
BJM powder using staining, including the biuret test, xanthoproteic test, 
Millon’s test, and lead acetate test. Of the four tests, the Biuret test is a 
protein-specific test, while the xanthoproteic, Millon’s, and lead acetate 
tests are amino acid-specific tests. The results of the tests were similar 
to those found in the studies by Chakraborty et al. (2015) toward B. 
bengalensis, a snail closely related to B. javanica, and showed positive 
results for containing proteins and amino acids [8].
CCl4 has long been recognized as a hepatotoxin, and many 
hepatoprotective compounds have been tested on animals to counter 
the effects of CCl4 [15]. CCl4 is known to be toxic toward both cells and 
tissues of the body, particularly to the liver and kidneys as both are 
sensitive to the presence of CCl4 in the body. The toxic effects of CCl4 are 
connected to CCl4 metabolism, which is catalyzed by the cytochrome 
P-450 enzyme system. In this process, trichloromethyl free radicals 
(CCl3) are produced in the liver and cause lipid peroxidation, irreversible 
binding to macromolecules, and calcium imbalance, leading to death or 
degeneration of liver cells [16]. Furthermore, steatosis, fatty liver, and 
cholestasis may also occur [17].
AST, ALT, and ALP are markers that are sensitive to hepatocyte damage. 
Transaminase enzymes are highly concentrated in the liver, and an 
increase in enzyme activity confirms the damage in hepatocytes [15]. 
Damaged and acutely degenerated cells then release intracellular 
Table 3: Determining the level of damage in semiquantitative 




1 0 Central vein and parenchymal cells are 
not damaged
2 20–40 Damage in the centrilobular area
3 >40 Damage in the central vein and 
parenchymal cells surrounding the 
central vein
Source: Afiati (2009)
Table 4: ALT and AST activity in the preliminary test at 340 nm 
wavelength
Measured Group Activity (UI/L)
7 days 14 days 21 days
AST plasma Normal control 20.07±0.69 21.17±0.54 19.75±1.21
2 g/kg weight dose 28.70±1.00 27.57±0.59 28.48±1.63
Negative control 60.93±0.80 62.36±0.32 60.85±1.50
ALT plasma Normal control 13.47±0.35 14.92±0.26 15.23±0.32
2 g/kg weight dose 19.88±1.12 18.59±0.34 19.11±0.69
Negative control 39.69±0.48 40.36±0.77 43.69±0.86
Activity scores in mean±SD. AST: Aminotransferase, ALT: Aspartate 
transaminase. SD: Standard deviation 
Table 5: Results of AST, ALT, and ALP activity (U/l)
Group Mean activity±SEM
AST (U/I) ALT (U/I) ALP (UI/L)
Normal control 18.06±0.92* 13.97±1.08* 117.71±5.69
Negative control 70.09±1.68# 63.55±2.69# 324.67±14.36#
Positive control 28.26±2.41#* 23.57±1.75#* 186.35±16.00
Dosage 1 65.82±2.24# 57.32±3.13# 321.77±13.73
Dosage 2 42.60±3.29#* 41.70±2.66#* 240.92±26.74*
Dosage 3 37.61±3.19#* 34.72±3.29#* 184.03±16.06*
Normal control (CMC 0.5% with a dose of 3 mL/200 g weight), negative 
control (CMC 0.5% with a dose of 3 mL/200 g weight), positive 
control (silymarin 9.45 g/200 g weight), dosage 1 (BJM powder 1 g/kg weight), 
dosage 2 (BJM powder 2 g/kg weight), and dosage 3 (BJM powder 1 g/kg 
weight). *A significant difference was found compared with the negative 
control group by the Mann–Whitney U-test (p<0.05). **A significant difference 
was found compared with the normal control group by the Mann–Whitney 
U-test (p<0.05). AST: Aminotransferase, ALT: Aspartate transaminase, 
ALP: Alkaline phosphatase, SEM: Standard error of the mean, BJM: Bellamya 
javanica meat. CMC: Carboxymethyl cellulose
Fig. 1: Diagram of the mean central vein diameter in white 
male mice 14 days after treatment. Group 1, normal control 
(carboxymethyl cellulose [CMC] 0.5%); Group 2, negative control 
(CMC 0.5%); Group 3, positive control (silymarin 9.45 mg/200 g 
mouse weight); Group 4, Bellamya javanica meat (BJM) powder 
with a dose of 1 g/kg mouse weight; Group 5, BJM powder with 
a dose of 2 g/kg mouse weight; and Group 6, BJM powder with a 
dose of 4 g/kg mouse weight
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proteins and other macromolecules into the bloodstream. Some 
proteins can be found only in the hepatocytes, and when they are 
detectable in the bloodstream, it is an additional indicator of liver 
damage. Some of these proteins are hepatocyte enzymes [16].
Overall, our results indicated that AST, ALT, and ALP activity 
decreased as the consumption of snail meat increased. This decrease 
likely occurred as a result of increased GSH synthesis, which is 
elicited by amino acids present in B. javanica, such as glutamine, 
cysteine, and glycine. This increase promotes a body defense 
toward oxidative stress caused by reactive oxygen species and CCl3 
from CCl4 metabolism in hepatocytes [2,18,19]. GSH activity as an 
antioxidant is a result of the presence of the Sulfhydryl (SH) chain, 
which is highly nucleophilic and very reactive toward electrophilic 
free radicals, conferring good affinity toward the free radicals 
produced from CCl4 [19,20].
Our results of AST, ALT, and ALP activity measurements were supported 
by histological examinations of the liver. Administering CCl4 caused 
damage to the liver lobes, including hepatocyte necrosis and neutrophil 
infiltration of the central vein and hepatocytes, indicating an increase 
in inflammatory processes in the area. Damage by free radicals initiates 
the activation of the immune system, such as Kupffer cells, which 
stimulate the infiltration of inflammatory cells from the plasma to the 
damaged tissue [21].
Fig. 3: Mouse liver histology of the negative control group after 
14 days of treatment (400× magnification). Notes: A - central vein; 
B - liver cells (hepatocytes); C - sinusoid; D - hepatocyte damage 
(necrosis); E - neutrophil infiltration
Fig. 2: Mouse liver histology for all treatment groups after 14 days of treatment (100× magnification). (a) Normal control, (b) negative 
control, (c) dosage 1 (1 g/kg weight), (d) dosage 2 (2 g/kg weight), (e) dosage 3 (4 g/kg weight); A - central vein; B - liver cells 
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CONCLUSION
In this study, we demonstrated that B. javanica has potential 
hepatoprotective effects, with the strongest protection occurring at a 
4 g/kg mouse weight dosage. Hepatoprotection was observed in the 
form of decreased AST, ALT, and ALP activity and relevant changes in 
liver histopathology. Furthermore, this decrease likely occurred as 
a result of increased GSH synthesis, which is elicited by amino acids 
present in B. javanica. A decrease in damaged hepatocyte size and the 
number and amount of neutrophil infiltration in the central vein were 
seen histologically with BJM treatment. It shows neutrophil infiltration 
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